ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

QNST vs AHG // PIOTROSKI F-SCORE QUALITY

QuinStreet Inc. (NASDAQ) VS. Akso Health Group ADS (NASDAQ) • 15-METRIC TALLY: QNST 7 — AHG 1
▲ PIOTROSKI F-SCORE QUALITY LEADER: QNST
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QNST VS. AHG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC QNST AHG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 10.10% -0.10% +10.20 QNST /gross-margins <GO>
Return on Invested Capital (ROIC) 2.60% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation 109.9x — — TIE /valuation <GO>
Free Cash Flow Yield 8.45% -1.12% +9.57 QNST /fcf-yield <GO>
Operating Margin 0.60% -60.00% +60.60 QNST /operating-margins <GO>
Net Profit Margin 0.40% -60.00% +60.40 QNST /net-margins <GO>
Revenue Growth (YoY) 78.30% -6.40% +84.70 QNST /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.24 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 7/9 2/9 +5.00 QNST /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.3 53.8 +7.57 QNST /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $980.8M $1.14B -$158.6M AHG /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR QNST REV AHG REV QNST GROSS % AHG GROSS % QNST FCF AHG FCF
FY 2025 $1.09B $13.8M 10.1% -0.1% $82.9M -$12.8M
FY 2024 $613.5M $14.8M 7.5% -1.9% $6.7M $1.0M
FY 2023 $580.6M $2.4M — — $11.8M $1.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QNST // BETA —
AHG // BETA —